Rahul D. Ballal, Director: Enliven Therapeutics ELVN Sell · Filed 24/04/12

Trade details

Type: Insider sale
Amount: $701,142
Shares · price: 30,300 sh · $23.14 a share
Held after: 45,441 sh
Stock: Enliven Therapeutics ELVN
Person: Rahul D. BallalDirector
Trade date: 24/04/11
Filed: 24/04/12
Days to filing: 1 days

Sold 40.0% of holdings

Share of holding sold: 40.0%

Enliven Therapeutics trades, last 26 weeks

What else happened in Enliven Therapeutics around then

Filed or reported within 30 days of the trade day · 24/03/12~24/05/11

Rahul D. Ballal's recent trades

Rahul D. BallalDirector
Sell10b5-1 planAgios Pharmaceuticals
Sell10b5-1 plan
Agios Pharmaceuticals
AGIO
$433.6K
8,132 sh
$433.6K
Filed 24/11/12
Traded 24/11/07
Rahul D. BallalDirector
Sell10b5-1 planAgios Pharmaceuticals
Sell10b5-1 plan
Agios Pharmaceuticals
AGIO
$288.7K
4,929 sh
$288.7K
Filed 24/11/12
Traded 24/11/08
Rahul D. BallalDirector
Sell10b5-1 planAgios Pharmaceuticals
Sell10b5-1 plan
Agios Pharmaceuticals
AGIO
$204.4K
3,571 sh
$204.4K
Filed 24/11/12
Traded 24/11/08
Rahul D. BallalDirector
Sell10b5-1 planAgios Pharmaceuticals
Sell10b5-1 plan
Agios Pharmaceuticals
AGIO
$101.6K
1,868 sh
$101.6K
Filed 24/11/12
Traded 24/11/07
Rahul D. BallalDirector
Sell10b5-1 planAgios Pharmaceuticals
Sell10b5-1 plan
Agios Pharmaceuticals
AGIO
$88.8K
1,500 sh
$88.8K
Filed 24/11/12
Traded 24/11/08

Rahul D. Ballal, Director — sold $701.1K of Enliven Therapeutics ELVN · 40.0% of holdings · 10b5-1 plan | Whalegun